Search research articles
Contact Us
Filters
Showing results (371-380 of 509) with videos related to
Page
of 51
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2016
Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France
Nicolas Penel, Jean-Michel Coindre, Sylvie Bonvalot, et al.
Cancer Medicine
|
December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group
Mehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
Archives of Pathology & Laboratory Medicine
|
December 8, 2024
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, et al.
BMC Cancer
|
November 7, 2015
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes)
Mathilde Penel-Page, Isabelle Ray-Coquard, Julie Larcade, et al.
Seminars in Oncology
|
December 18, 2017
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients
Ettore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, et al.
Cancer Medicine
|
June 30, 2018
Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study
Emmanuelle Bompas, Loïc Campion, Antoine Italiano, et al.
Gynecologic Oncology
|
December 25, 2021
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
Philipp Harter, Marie Ange Mouret-Reynier, Sandro Pignata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 18, 2025
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME database
Thomas Papazyan, Elodie Martin, Patricia Pautier, et al.
Gynecologic Oncology
|
April 4, 2020
Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group
Audrey Chevrot, Nicolas Pouget, Anne-Sophie Bats, et al.
The Lancet. Oncology
|
February 21, 2020
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial
Antoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, et al.
Page
of 51
Search research articles
Search
Showing results (371-380 of 509) with videos related to
Sort By:
Page
of 51
European Journal of Cancer (Oxford, England : 1990)
|
March 15, 2016
Management of desmoid tumours: A nationwide survey of labelled reference centre networks in France
Nicolas Penel, Jean-Michel Coindre, Sylvie Bonvalot, et al.
Cancer Medicine
|
December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group
Mehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
Archives of Pathology & Laboratory Medicine
|
December 8, 2024
Can Morphology and Immune Infiltration Predict the Homologous Recombination Deficiency Status in Newly Diagnosed High-Grade Serous Ovarian Carcinoma?
Amel Kime, Guillaume Bataillon, Isabelle Treilleux, et al.
BMC Cancer
|
November 7, 2015
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes)
Mathilde Penel-Page, Isabelle Ray-Coquard, Julie Larcade, et al.
Seminars in Oncology
|
December 18, 2017
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients
Ettore Capoluongo, Gillian Ellison, José Antonio López-Guerrero, et al.
Cancer Medicine
|
June 30, 2018
Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study
Emmanuelle Bompas, Loïc Campion, Antoine Italiano, et al.
Gynecologic Oncology
|
December 25, 2021
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial
Philipp Harter, Marie Ange Mouret-Reynier, Sandro Pignata, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 18, 2025
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME database
Thomas Papazyan, Elodie Martin, Patricia Pautier, et al.
Gynecologic Oncology
|
April 4, 2020
Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group
Audrey Chevrot, Nicolas Pouget, Anne-Sophie Bats, et al.
The Lancet. Oncology
|
February 21, 2020
Cabozantinib in patients with advanced Ewing sarcoma or osteosarcoma (CABONE): a multicentre, single-arm, phase 2 trial
Antoine Italiano, Olivier Mir, Simone Mathoulin-Pelissier, et al.
Page
of 51